Innovacell (TSE:504A) Other Financing: 円0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:504A Innovacell Inc TSE:504A
10 GF Score
Price 円453.00
View Full Analysis

What is Innovacell Other Financing?

Innovacell TSE:504A -7.93% 10 Other Financing is 円0.00 Mil as of Dec. 2025. GuruFocus rates TSE:504A with a GF Score™ of 10/100.

Innovacell's Other Financing for the three months ended in Dec. 2025 was 円0.00 Mil.

Innovacell's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was 円0.00 Mil.

Innovacell Other Financing Historical Data

* Premium members only.

The historical data trend for Innovacell's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovacell Other Financing Chart

Innovacell Annual Data
Trend Dec23 Dec24 Dec25
Other Financing
-0.00 104.50 1,874.19

Innovacell Quarterly Data
Dec23 Dec24 Sep25 Dec25 Mar26
Other Financing 0.00 0.00 0.00 0.00 0.00
TSE:504A
10GF Score
Innovacell Inc TSE:504A
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innovacell Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of 円0.00 Mil mean?
Innovacell (TSE:504A) has a Other Financing of 円0.00 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Innovacell and its competitors.
Is Innovacell's Other Financing too high?
Innovacell's current Other Financing is 円0.00 Mil. Overall, Innovacell has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Innovacell's Other Financing compare to VRTX and REGN?
Innovacell's Other Financing of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Innovacell and its competitors. Innovacell's current Other Financing is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovacell stock overvalued right now?
Innovacell (TSE:504A) has a current Other Financing of 円0.00 Mil. The current Other Financing is 円0.00 Mil. Innovacell's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Innovacell (TSE:504A), the current Other Financing is 円0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovacell Business Description

Address 3-5-11 Kamiosaki, Meguro Villa Garden, 5th floor, Shinagawa-ku, Tokyo, JPN, 141-0021
Innovacell Inc is engaged in the development, manufacturing, and sale of regenerative medicine products for the treatment of conditions including fecal and urinary incontinence. Its activities include researching potential therapeutic candidates, developing formulations, and commercializing products in the markets. The company is working on the development and commercialization of the following three cell therapy pipelines targeting incontinence (fecal and urinary incontinence): ICEF15, ICEF16, and ICES13.
10GF Score

Get the complete analysis for TSE:504A

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円453.00
Price